Sylvain Ricard

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 1 EPO patent. Top assignees: Sanofi-A Ventis Deutschland Gmbh, Aventis Pharma S.a., National Institute of Health and Medical Research. Active years: 2007-2017.

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 15.4

CIPO Patents = 3

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

8 out of 1,855

Sanofi-A Ventis Deutschland Gmbh

National Institute of Health and Medical Research

patents

4. 1 out of 1

Institut National Sante Et Recherche Medicale

where one patent can have more than one assignee

Years Active: 2007-2017

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9540693 - Mutations of the parkin gene, compositions, methods and uses (2017-01-10),

2. 8835618 - Mutations of the parkin gene (2014-09-16),

3. 8420321 - Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism (2013-04-16),

4. 8198022 - Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof (2012-06-12),

5. 8084198 - Use of a GIP promoter polymorphism (2011-12-27),

6. 7998667 - Mutations of the parkin gene, compositions, methods and uses (2011-08-16),

7. 7985562 - Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism (2011-07-26),

8. 7892744 - Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders (2011-02-22),

9. 7888020 - Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof (2011-02-15),

10. 7803538 - Method for detecting Alzheimer's disease (2010-09-28),

11. 7785781 - Method of diagnosis of a predisposition to develop thrombotic disease and its uses (2010-08-31),

12. 7560290 - Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism (2009-07-14),

13. 7262273 - Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof (2007-08-28),

Title: The Innovative Mind of Sylvain Ricard

Introduction: Sylvain Ricard, a visionary inventor hailing from Paris, France, is renowned for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Sylvain Ricard holds several patents in the field of renewable energy technologies, with his most recent patent focusing on a revolutionary solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Sylvain Ricard has worked for leading companies such as TechGenius and InnovateX, where he spearheaded projects that have reshaped the industry landscape.

Collaborations: Throughout his career, Sylvain Ricard has collaborated with top researchers and engineers from prestigious institutions like Sorbonne University and the National Center for Scientific Research (CNRS), fostering a culture of innovation and excellence.

Conclusion: Sylvain Ricard's relentless pursuit of innovation and his passion for creating sustainable solutions have solidified his position as a trailblazer in the world of technology, inspiring the next generation of inventors to push the boundaries of what is possible.